A large deletion, spanning exons 1 to 25 of F8 gene, and a high-titer factor VIII inhibitor, in severe hemophilia A

被引：1

作者：

Mousavi, Sayed Hamid ^{[1
,2
]}

Mesbah-Namin, Seyed Alireza ^{[3
]}

Zeinali, Sirous ^{[4
]}

Jazebi, Mohammad ^{[5
]}

Dabbagh, Ali ^{[6
]}

Hosseini, Sayed Mohammad Reza ^{[7
]}

Zafarghandi Motlagh, Fatemeh ^{[8
]}

Shiravand, Yavar ^{[9
]}

Dorgalaleh, Akbar ^{[9
]}

机构：

[1] Kateb Univ, Dept Clin Biochem, Fac Med Sci, Kabul, Afghanistan

[2] Afghanistan Natl Char Org Special Dis ANCOSD, Kabul, Afghanistan

[3] Tarbiat Modares Univ, Dept Clin Biochem, Fac Med Sci, Tehran, Iran

[4] Pasteur Inst Iran, Biotechnol Res Ctr, Iranian Mol Med Network, Tehran, Iran

[5] Iranian Comprehens Hemophilia Care Ctr ICHCC, Tehran, Iran

[6] Shahid Beheshti Univ Med, Anesthesiol Dept, Anesthesiol Res Ctr, Tehran, Iran

[7] Ghalib Univ, Dept Publ Hlth, Kabul, Afghanistan

[8] Kawsar Human Genet Res Ctr, Dr Zeinalis Med Genet Lab, Tehran, Iran

[9] Iran Univ Med Sci, Sch Allied Med, Dept Hematol & Blood Transfus, Tehran, Iran

来源：

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2020年 / 42卷 / 03期

关键词：

bleeding; deletion; hemophilia; inhibitor; mortality;

D O I：

10.1111/ijlh.13174

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E138 / E140

页数：3

共 10 条

[1] The identification and classification of 41 novel mutations in the factor VIII gene (F8C)
Cutler, JA
Mitchell, MJ
Smith, MP
Savidge, GF
[J]. HUMAN MUTATION, 2002, 19 (03) : 274 - 278
[2] A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors
Fujita, J.
Miyawaki, Y.
Suzuki, A.
Maki, A.
Okuyama, E.
Murata, M.
Takagi, A.
Murate, T.
Suzuki, N.
Matsushita, T.
Saito, H.
Kojima, T.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) : 2099 - 2107
[3] The molecular basis of hemophilia A: Genotype-phenotype relationships and inhibitor development
Goodeve, AC
Peake, IR
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 (01) : 23 - 30
[4] Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
Goudemand, J
Rothschild, C
Demiguel, V
Vinciguerrat, C
Lambert, T
Chambost, H
Borel-Derlon, A
Claeyssens, S
Laurian, Y
Calvez, T
[J]. BLOOD, 2006, 107 (01) : 46 - 51
[5] F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Gouw, Samantha C.
van den Berg, H. Marijke
Oldenburg, Johannes
Astermark, Jan
de Groot, Philip G.
Margaglione, Maurizio
Thompson, Arthur R.
van Heerde, Waander
Boekhorst, Jorien
Miller, Connie H.
le Cessie, Saskia
van der Bom, Johanna G.
[J]. BLOOD, 2012, 119 (12) : 2922 - 2934
[6] Hemophilia A in Afghanistan, the first report
Mousavi, Sayad Hamid
Tabibian, Shadi
Motlagh, Hoda
Dorgalaleh, Akbar
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (07) : 357 - 360
[7] Genetic diagnosis in hemophilia and von Willebrand disease
Swystun, Laura L.
James, Paula D.
[J]. BLOOD REVIEWS, 2017, 31 (01) : 47 - 56
[8] VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247
[9] The haemophilia A mutation search test and resource site, home page of the factor VIII mutation database: HAMSTeRS
Wacey, AI
KemballCook, G
Kazazian, HH
Antonarakis, SE
Schwaab, R
Lindley, P
Tuddenham, EGD
[J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (01) : 100 - 102
[10] Characterization of large deletions in the F8 gene using multiple competitive amplification and the genome walking technique
You, G. L.
Ding, Q. L.
Lu, Y. L.
Dai, J.
Xi, X. D.
Wang, X. F.
Wang, H. L.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (06) : 1103 - 1110

← 1 →